lobbying_activities: 1995725

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1995725	91b075d2-d59d-4f83-ab2a-9599cdebf2c8	Q2	FORGE FEDERAL AFFAIRS LLC	400865535	LILLY USA LLC	2017	second_quarter	PHA	Issues related to pricing of prescription drugs. Opposition to prescription drug importation. Support for funding of Department of Homeland Security drug interdiction efforts. Issues related to reauthorization of the Prescription Drug User Fee Act. H.R.2430/S.934, FDA Reauthorization Act of 2017.	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2017-07-19T12:19:53.483000-04:00